In this new whitepaper, experts from Medpace discuss the challenges and strategies for success in the clinical development of cell therapies.
Read More
Medpace is highlighted in a recent interview in Clinical Leader: A Stem Cell Company Overcomes The Challenges Of International Trials.
Read More
Medpace’s Regulatory Submissions Manager, Jan Ohotski, and Clinical Trial Manager, Elizabeth Shepherd, discuss how to operationalize advance therapy clinical trials using hard-won lessons learned from Medpace’s years of experience.
Read More
We are delighted to announce our participation in Rare Disease Day for another consecutive year. In addition to our internal activities, Medpace will be hosting a webinar on how advanced therapies are dramatically changing the way patients are treated for a wide variety of diseases – particularly for patients with rare diseases and orphan indications.
Read More
Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development
Read More
Several weeks ago, we announced that Dr. Gregory Hale joined the Medpace medical leadership team. He is an experienced physician with clinical expertise in bone marrow transplantation, cellular therapies, and hematologic malignancies. We were eager to sit down with Dr. Hale to learn more about what attracted him to the Medpace model and what new innovations he is most excited about.
Read More